BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36745394)

  • 1. Systematic Evaluation of Local and Global Machine Learning Models for the Prediction of ADME Properties.
    Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2023 Mar; 20(3):1758-1767. PubMed ID: 36745394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapting Deep Learning QSPR Models to Specific Drug Discovery Projects.
    Fluetsch A; Di Lascio E; Gerebtzoff G; Rodríguez-Pérez R
    Mol Pharm; 2024 Apr; 21(4):1817-1826. PubMed ID: 38373038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progresses in the exploration of machine learning methods as in-silico ADME prediction tools.
    Tao L; Zhang P; Qin C; Chen SY; Zhang C; Chen Z; Zhu F; Yang SY; Wei YQ; Chen YZ
    Adv Drug Deliv Rev; 2015 Jun; 86():83-100. PubMed ID: 26037068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the limitations in the prediction of PAMPA permeability with machine learning algorithms.
    Rácz A; Vincze A; Volk B; Balogh GT
    Eur J Pharm Sci; 2023 Sep; 188():106514. PubMed ID: 37402429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets.
    Zhou Y; Cahya S; Combs SA; Nicolaou CA; Wang J; Desai PV; Shen J
    J Chem Inf Model; 2019 Mar; 59(3):1005-1016. PubMed ID: 30586300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-ADME relationship: still a long way to go?
    Hou T; Wang J
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):759-70. PubMed ID: 18611116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery.
    Bhatia AS; Saggi MK; Kais S
    J Chem Inf Model; 2023 Nov; 63(21):6476-6486. PubMed ID: 37603536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Model-based Target Pharmacology Assessment (mTPA): An Approach Using PBPK/PD Modeling and Machine Learning to Design Medicinal Chemistry and DMPK Strategies in Early Drug Discovery.
    Chen EP; Bondi RW; Michalski PJ
    J Med Chem; 2021 Mar; 64(6):3185-3196. PubMed ID: 33719432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico ADME-Tox modeling: progress and prospects.
    Alqahtani S
    Expert Opin Drug Metab Toxicol; 2017 Nov; 13(11):1147-1158. PubMed ID: 28988506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets.
    Korotcov A; Tkachenko V; Russo DP; Ekins S
    Mol Pharm; 2017 Dec; 14(12):4462-4475. PubMed ID: 29096442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of machine learning and nonlinear statistical tools for ADME prediction.
    Sakiyama Y
    Expert Opin Drug Metab Toxicol; 2009 Feb; 5(2):149-69. PubMed ID: 19239395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of ADME properties with substructure pattern recognition.
    Shen J; Cheng F; Xu Y; Li W; Tang Y
    J Chem Inf Model; 2010 Jun; 50(6):1034-41. PubMed ID: 20578727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective Validation of Machine Learning Algorithms for Absorption, Distribution, Metabolism, and Excretion Prediction: An Industrial Perspective.
    Fang C; Wang Y; Grater R; Kapadnis S; Black C; Trapa P; Sciabola S
    J Chem Inf Model; 2023 Jun; 63(11):3263-3274. PubMed ID: 37216672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of In Vivo Pharmacokinetic Parameters and Time-Exposure Curves in Rats Using Machine Learning from the Chemical Structure.
    Obrezanova O; Martinsson A; Whitehead T; Mahmoud S; Bender A; Miljković F; Grabowski P; Irwin B; Oprisiu I; Conduit G; Segall M; Smith GF; Williamson B; Winiwarter S; Greene N
    Mol Pharm; 2022 May; 19(5):1488-1504. PubMed ID: 35412314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Comparison of Machine Learning and Mechanistic In Vitro-In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance.
    Keefer CE; Chang G; Di L; Woody NA; Tess DA; Osgood SM; Kapinos B; Racich J; Carlo AA; Balesano A; Ferguson N; Orozco C; Zueva L; Luo L
    Mol Pharm; 2023 Nov; 20(11):5616-5630. PubMed ID: 37812508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction.
    Liu X; Feng H; Wu J; Xia K
    Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33837771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.